ConvaTec Group PLC Director/PDMR Shareholding (1280H)
30 Luglio 2021 - 4:45PM
UK Regulatory
TIDMCTEC
RNS Number : 1280H
ConvaTec Group PLC
30 July 2021
30 July 2021
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 30 July 2021, Professor Constantin Coussios, Non-Executive
Director and a PDMR, purchased 8,440 Shares at GBP2.356227 per
share. His resulting shareholding is 8,440 Shares.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Professor Constantin Coussios
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc
instrument, type of instrument ("Shares")
Identification code GB00BD3VFW73
b) Nature of the transaction Purchase of Shares on 30 July 2021
c) Price(s) and volume(s) Price(s) Volume(s)
2.356227 8,440
d) Aggregated information
- Aggregated volume 8,440
- Price 19,886.56
e) Date of the transaction 2021-07-30
f) Place of the transaction London Stock Exchange, Main Market (XLON)
Enquiries
Analysts and Investors
Kate Postans, VP of IR & Corporate Communications +44 (0)782 644 7807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our products
provide a range of clinical and economic benefits including
infection prevention, protection of at-risk skin, improved patient
outcomes and reduced total cost of care. To learn more about
ConvaTec, please visit www.convatecgroup.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFSSDFIIVIL
(END) Dow Jones Newswires
July 30, 2021 10:45 ET (14:45 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Apr 2023 a Apr 2024